GREGORY JAHANGIRI: Open Payments
NPI 1689854986 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 9 payments from 5 companies in 2025. Trend: 2023 $45 · 2024 $128 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $147 |
| Novo Nordisk Inc | 4 | $103 |
| Alkermes, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Cranial Technologies, Inc | 1 | $21 |
Products named: ZEPBOUND, Ozempic, VIVITROL, MOUNJARO, Wegovy, Cologuard Collection Kit, Doc Band.
Industry payments across CA — which companies pay providers there.
